KIR3DL2 IS EXPRESSED IN PERIPHERAL T‐CELL LYMPHOMAS AND MAY BE A THERAPEUTIC TARGET. (12th June 2019) - Cheminant, M.; Decroos, A.; Bruneau, J.; Carras, S.; Pelletier, L.; Martin, N.; Peri, V.; Guillot, F.; Paturel, C.; Sicard, H.; Bonnafous, C.; Lhermitte, L.; et al.